Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Pfe crawled time : 14:20 save search
BioCryst Appoints Dr. Nancy Hutson as Chair of the Board
Published: 2023-03-31 (Crawled : 14:20) - globenewswire.com
ENDPQ | $0.0006 3.4K
|
n/a
|
| O: -2.05%
H: 11.75%
C: -2.1%
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: 0.42%
H: 0.69%
C: 0.62%
CLSD | $1.35 2.27% 35K
|
Health Technology
|
| O: 2.4%
H: 7.14%
C: 6.12%
BCRX | $4.535 0.78% 270K
|
Health Technology
|
| O: 1.07%
H: 0.94%
C: -1.65%
Erasca Announces Clinical Trial Collaboration and Supply Agreement with Pfizer to Evaluate ERAS-007 and Palbociclib Combination
Published: 2022-10-20 (Crawled : 14:20) - biospace.com/
ERAS | $1.81 1.12% 58K
|
|
| O: 2.12%
H: 1.24%
C: -1.94%
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: 0.37%
H: 0.32%
C: -0.83%
eras-007 collaboration trial agreement
Anticoagulants Market is expected to generate a revenue of USD 56.16 Billion by 2028, Globally, at 10.20% CAGR: Verified Market Research®
Published: 2022-10-06 (Crawled : 14:20) - prnewswire.com
GLAXF | $20.2 0.65% 0
|
Health Technology
|
| O: -2.53%
H: 0.0%
C: 0.0%
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: -0.82%
H: 0.03%
C: -1.53%
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -0.3%
H: 0.0%
C: 0.0%
GSK | $39.565 0.75% 170K
|
Health Technology
|
| O: -1.25%
H: 0.53%
C: -0.1%
BMY | $48.295 -0.01% 920K
|
Health Technology
|
| O: -0.92%
H: 0.06%
C: -0.78%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
research expected market
Pfizer and BioNTech Granted FDA Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster for Ages 12 Years and Older
Published: 2022-08-31 (Crawled : 14:20) - globenewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 0.75%
H: 1.98%
C: 1.98%
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: 0.35%
H: 0.6%
C: -1.7%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
BNTX | $86.43 0.3% 60K
|
Health Technology
|
| O: 0.63%
H: 1.42%
C: -2.27%
covid-19 fda vaccine granted authorization
Astellas Highlights Data on Advanced and Rare Cancers during 2022 ASCO Annual Meeting and EHA 2022 Hybrid Congress
Published: 2022-05-12 (Crawled : 14:20) - prnewswire.com
ALPMY | $9.47 520K
|
Manufacturing
|
| O: -0.2%
H: 1.54%
C: 0.57%
PFE A | $25.44 0.2% 4.4M
|
Health Technology
|
| O: -0.8%
H: 0.0%
C: 0.0%
rare asco cancer
Gainers vs Losers
| 83% | 17% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0835 131.94% 160M
|
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
LIFW | News | $0.99 19.26% 800K
|
Administrative and Support and ...
Your saved searches
Save your searches and get alerts when important news are released.